Others｜司会・講師のご紹介

Others｜Disccusion１（頭頸部がん）

Others｜Disccusion２（悪性黒色腫）

解説【LBA36】A randomised phase II study to evaluate the efficacy and safety of androgen deprivation therapy (ADT) vs chemotherapy (CT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancers.
【849O】Phase II study of trastuzumab deruxtecan in patients with HER2-positive recurrent/metastatic salivary gland cancer: results from the MYTHOS trial

清田 尚臣　Kiyota Naomi
（神戸大学医学部附属病院 腫瘍センター）

解説【LBA41】Long-term survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
【LBA42】Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: the NADINA trial

清田 尚臣　Kiyota Naomi
（神戸大学医学部附属病院 腫瘍センター）

解説【852MO】REWRITE–GORTEC 2018-02: Radiotherapy-durvalumab without prophylactic neck irradiation in squamous cell carcinoma of the head and neck

清田 尚臣　Kiyota Naomi
（神戸大学医学部附属病院 腫瘍センター）